Literature DB >> 19337829

Dysregulation of calcium homeostasis in Alzheimer's disease.

David H Small1.   

Abstract

The accumulation of oligomeric species of beta-amyloid protein in the brain is considered to be a key factor that causes Alzheimer's disease (AD). However, despite many years of research, the mechanism of neurotoxicity in AD remains obscure. Recent evidence strongly supports the theory that Ca2+ dysregulation is involved in AD. Amyloid proteins have been found to induce Ca2+ influx into neurons, and studies on transgenic mice suggest that this Ca2+ influx may alter neuronal excitability. The identification of a risk factor gene for AD that may be involved in the regulation of Ca2+ homeostasis and recent findings which suggest that presenilins may be involved in the regulation of intracellular Ca2+ stores provide converging lines of evidence that support the idea that Ca2+ dysregulation is a key step in the pathogenesis of AD.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19337829     DOI: 10.1007/s11064-009-9960-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  56 in total

Review 1.  Alzheimer's disease and the amyloid beta protein: What is the role of amyloid?

Authors:  D H Small; C A McLean
Journal:  J Neurochem       Date:  1999-08       Impact factor: 5.372

2.  A polymorphism in CALHM1 influences Ca2+ homeostasis, Abeta levels, and Alzheimer's disease risk.

Authors:  Ute Dreses-Werringloer; Jean-Charles Lambert; Valérie Vingtdeux; Haitian Zhao; Horia Vais; Adam Siebert; Ankit Jain; Jeremy Koppel; Anne Rovelet-Lecrux; Didier Hannequin; Florence Pasquier; Daniela Galimberti; Elio Scarpini; David Mann; Corinne Lendon; Dominique Campion; Philippe Amouyel; Peter Davies; J Kevin Foskett; Fabien Campagne; Philippe Marambaud
Journal:  Cell       Date:  2008-06-27       Impact factor: 41.582

3.  Amyloid beta protein forms ion channels: implications for Alzheimer's disease pathophysiology.

Authors:  H Lin; R Bhatia; R Lal
Journal:  FASEB J       Date:  2001-11       Impact factor: 5.191

4.  Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease.

Authors:  J Sáez-Valero; G Sberna; C A McLean; D H Small
Journal:  J Neurochem       Date:  1999-04       Impact factor: 5.372

5.  The amyloid beta-protein of Alzheimer's disease increases acetylcholinesterase expression by increasing intracellular calcium in embryonal carcinoma P19 cells.

Authors:  G Sberna; J Sáez-Valero; K Beyreuther; C L Masters; D H Small
Journal:  J Neurochem       Date:  1997-09       Impact factor: 5.372

6.  Presenilin mutations linked to familial Alzheimer's disease cause an imbalance in phosphatidylinositol 4,5-bisphosphate metabolism.

Authors:  Natalie Landman; Soon Youn Jeong; Sun Young Shin; Sergey V Voronov; Geo Serban; Min Suk Kang; Myung Kyu Park; Gilbert Di Paolo; Sungkwon Chung; Tae-Wan Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-08       Impact factor: 11.205

Review 7.  Regulation of APP cleavage by alpha-, beta- and gamma-secretases.

Authors:  J Nunan; D H Small
Journal:  FEBS Lett       Date:  2000-10-13       Impact factor: 4.124

Review 8.  A beta oligomers - a decade of discovery.

Authors:  Dominic M Walsh; Dennis J Selkoe
Journal:  J Neurochem       Date:  2007-02-05       Impact factor: 5.372

9.  Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1996-08       Impact factor: 17.088

10.  The neuropsychological diagnosis of Alzheimer's disease.

Authors:  Elsdon Storey; Glynda J. Kinsella; Melissa J. Slavin
Journal:  J Alzheimers Dis       Date:  2001-06       Impact factor: 4.472

View more
  33 in total

Review 1.  TRPC channels and their implication in neurological diseases.

Authors:  Senthil Selvaraj; Yuyang Sun; Brij B Singh
Journal:  CNS Neurol Disord Drug Targets       Date:  2010-03       Impact factor: 4.388

2.  In Vivo Chimeric Alzheimer's Disease Modeling of Apolipoprotein E4 Toxicity in Human Neurons.

Authors:  Ramsey Najm; Kelly A Zalocusky; Misha Zilberter; Seo Yeon Yoon; Yanxia Hao; Nicole Koutsodendris; Maxine Nelson; Antara Rao; Alice Taubes; Emily A Jones; Yadong Huang
Journal:  Cell Rep       Date:  2020-07-28       Impact factor: 9.423

Review 3.  Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration.

Authors:  Roberto Bravo; Valentina Parra; Damián Gatica; Andrea E Rodriguez; Natalia Torrealba; Felipe Paredes; Zhao V Wang; Antonio Zorzano; Joseph A Hill; Enrique Jaimovich; Andrew F G Quest; Sergio Lavandero
Journal:  Int Rev Cell Mol Biol       Date:  2013       Impact factor: 6.813

4.  Age-dependent effect of apolipoprotein E4 on functional outcome after controlled cortical impact in mice.

Authors:  Rebekah C Mannix; Jimmy Zhang; Juyeon Park; Xuan Zhang; Kiran Bilal; Kendall Walker; Rudolph E Tanzi; Giuseppina Tesco; Michael J Whalen
Journal:  J Cereb Blood Flow Metab       Date:  2010-06-30       Impact factor: 6.200

5.  Overlooked Alzheimer's smoking gun?

Authors:  Jan Ríčný
Journal:  Neurochem Res       Date:  2013-06-07       Impact factor: 3.996

Review 6.  Molecular Pathogenesis of Alzheimer's Disease: An Update.

Authors:  Alfredo Sanabria-Castro; Ileana Alvarado-Echeverría; Cecilia Monge-Bonilla
Journal:  Ann Neurosci       Date:  2017-04-21

7.  Proteolysis of calcineurin is increased in human hippocampus during mild cognitive impairment and is stimulated by oligomeric Abeta in primary cell culture.

Authors:  Hafiz Mohmmad Abdul; Irfan Baig; Harry Levine; Rodney P Guttmann; Christopher M Norris
Journal:  Aging Cell       Date:  2010-12-08       Impact factor: 9.304

Review 8.  Hybrids: a new paradigm to treat Alzheimer's disease.

Authors:  Manjinder Singh; Maninder Kaur; Navriti Chadha; Om Silakari
Journal:  Mol Divers       Date:  2015-09-02       Impact factor: 2.943

Review 9.  Presenilin transgenic mice as models of Alzheimer's disease.

Authors:  Gregory A Elder; Miguel A Gama Sosa; Rita De Gasperi; Dara L Dickstein; Patrick R Hof
Journal:  Brain Struct Funct       Date:  2009-11-18       Impact factor: 3.270

10.  2-Cyclopropylimino-3-methyl-1,3-thiazoline hydrochloride protects against beta-amyloid-induced activation of the apoptotic cascade in cultured cortical neurons.

Authors:  Eun-A Kim; Chang Hun Cho; Hoh-Gyu Hahn; Soo Young Choi; Sung-Woo Cho
Journal:  Cell Mol Neurobiol       Date:  2014-07-11       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.